Cite
HARVARD Citation
Irie, H. et al. (2020). Acquired resistance to trastuzumab/pertuzumab or to T‐DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728. Cancer science. 111 (6), pp. 2123-2131. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Irie, H. et al. (2020). Acquired resistance to trastuzumab/pertuzumab or to T‐DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728. Cancer science. 111 (6), pp. 2123-2131. [Online].